Home » Novocure Announces FDA Approval of the NovoTAL System
Novocure Announces FDA Approval of the NovoTAL System
The FDA has approved the NovoTAL system through a premarket approval supplement. The NovoTAL system allows certified physicians to use the individual MRI data of recurrent glioblastoma multiforme patients to optimize the field distribution and intensity of tumor-treating therapy.
The Sacramento Bee
The Sacramento Bee
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May